Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 8, 2003, Pages 1691-1698

  Wolpert, Christian ^a,d   Jung, Werner ^b   Spehl, Susanne ^a   Schimpf, Rainer ^a   Omran, Heyder ^a   Schumacher, Burghard ^a   Esmailzadeh, Bahman ^a   Tenzer, Dirk ^a   Mehra, Rahul ^c   Lüderitz, Berndt ^a  

^a UNIVERSITY OF BONN   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

^c MEDTRONIC INC   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Implantable defibrillator

Indexed keywords

AMIODARONE; DIGOXIN; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DEFIBRILLATOR; DUAL CHAMBER DEFIBRILLATOR; FEMALE; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; MALE; PAROXYSMAL TACHYCARDIA; STROKE; SUPRAVENTRICULAR TACHYCARDIA;

ALGORITHMS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0041699709     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00254.x     Document Type: Article

References (25)

1. Best PJ, Hayes DL, Stanton MS. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. PACE 1999; 22:79-85.
2. Heisel A, Jung J, Buob A, et al. The atrial defibrillator: A stand-alone device or part of a combined dual-chamber system? Am J Cardiol 1999; 83:218D-226D.
3. Lavergne T, Daubert JC, Chauvin M, et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20:182-188.
4. Geelen P, Lorga Filho A, Chauvin M, et al. The value of DDD pacing in patients with an implantable cardioverter defibrillator. PACE 1997; 20:177-181.
5. Luceri RM, Accerti PR. Temporary transvenous cardioversion and defibrillation: A new method for practical tachyarrhythmia management. PACE 1997; 20:168-172.
6. Heisel A, Jung J, Fries R, et al. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system. PACE 1997; 20:65-71.
7. Gilberg J, Brown M, Stanton M. et al. Clinical testing of a dual chamber atrial tachyarrhythmia detection algorithm. Comput Cardiol 1996; 23:57-60.
8. Brown M, Gillberg J, Stanton M, et al. Acute human testing of a dual chamber ventricular tachyarthythmia detection algorithm at Mayo Clinic. Comput Cardiol 1996; 23:61-64.
9. Jung W, Lüderitz B. Implantation of an arrhythmia management system for patients with ventricular and supraventricular tachyarrhythmias. Lancet 1997; 349:853-854.
10. Wolpert C, Jung W, Spehl S, et al. Increased specificity for supraventricular tachycardias: A new algorithm in a dual-chamber cardioverter-defibrillator. Circulation 1997; 96(Suppl.):I-720.
11. Swerdlow CD, Schöls W, Dijkman B, et al. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation 2000; 101:878-885.
12. Wolpert C, Jung W, Scholl C, et al. Electrical proarrhythmia: Induction of inappropriate atrial therapies due to far-field R-wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol 1998; 9:859-863.
13. Tse HF, Lau CP, Ayers GM. Detection of atrial fibrillation during sinus tachycardia induced by exercise in patients with implantable atrial defibrillators. PACE 1999; 22:247-252.
14. Tse HF, Lau CP, Sra JS, et al. Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: Implications for long-term efficacy and safety. The Metrix Investigators. Circulation 1999; 99:1446-1451.
15. Sra J, Biehl M, Blanck Z, et al. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. PACE 1998; 21:1105-1110.
16. Jung W, Wolpert C, Esmailzadeh B, et al. Specific considerations with the automatic implantable atrial defibrillator. J Cardiovasc Electrophysiol 1998; 9:S193-201.
17. Sra JS, Magli C, Dhala A, et al. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation. J Am Coll Cardiol 1996; 15:1532-1538.
18. Wellens HJ, Lau CP, Luderitz B, et al. An implantable device for the treatment of atrial fibrillation. Circulation 1998; 98:1651-1656.
19. Lüderitz B, Jung W. Quality of life of patients with atrial fibrillation. In M Santini (ed.): Progress in Clinical Pacing. Armonk, NY, Futura Media Services Inc., 1997, pp. 253-262.
20. Dijkman B, Wellens HJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000; 11:1196-1205.
21. Daoud EG, Timmermans C, Fellows C, et al. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators. Circulation 2000; 102:1407-1413.
22. Saksena S, Prakash A, Krol RB, et al. Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol 1999; 84:880-889.
23. Wilkoff BL, Kühlkamp V, Volosin K, et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001; 103:381-386.
24. Adler SW, Wolpert C, Warman EN, et al. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001; 104:887-892.
25. Gold MR, Sulke N, Schwartzman DS, et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001; 12:1247-1253.